PALO ALTO, Calif., March 17, 2019 /PRNewswire/ — ReCor Medical, Inc. (“ReCor”) announced the 6 month “on-medication” results from its RADIANCE-HTN SOLO clinical trial with simultaneous publication in Circulation, and the first randomization of patients in its RADIANCE-II pivotal trial of its Paradise® Renal Denervation System for the treatment of uncontrolled hypertension. Today at […]
Peripheral/Endo
Endospan Secures CE Mark Approval for Branched Endovascular Repair of the Aortic Arch with Its NEXUS™ Aortic Arch Repair System
March 19, 2019 08:30 AM Eastern Daylight Time HERZLIA, Israel–(BUSINESS WIRE)–Endospan, a pioneer in off-the-shelf, minimally invasive endovascular repair of Aortic Arch Disease comprising both aneurysms and dissections, today announced that it has received CE-marking for its NEXUS™ Stent Graft System. Diseases of the aortic arch present surgeons with challenging […]
BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease
FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow […]
Proximo Medical Announces New Client Win With EMBA
CASTLE PINES, Colo., March 13, 2019 /PRNewswire/ — Proximo Medical today announced that it has been selected as the marketing and commercialization partner of choice for EMBA Medical™ Limited, a medical device company that designs and develops peripheral embolization technologies focused on improving safety, control, and outcomes. Proximo Medical, a revenue-accelerating, risk-sharing, reduced-cost approach to […]
Micro Medical Solutions Signs Distribution Agreements in 15 Countries for MicroStent Vascular Stent
WILMINGTON, Mass., March 12, 2019 /PRNewswire/ — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has established distribution agreements for MicroStent in 15 countries in the European Union and Latin America. MicroStent is a vascular stent specifically […]
Fist Assist Devices, LLC Announces Formation of Global Medical Advisory Board Led by Dialysis Access Center Medical Director Dr. John Ross
LOS ALTOS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, a novel medical device start-up based in Silicon Valley, Calif., today announced the formation of its first global medical advisory board (MAB). Fist Assist Devices, LLC has developed the only wearable patent-protected intermittent compression device for vein dilation for patients with end-stage renal […]
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today announced that Company management will present at the Cowen and Company 39th Annual Health Care Conference in Boston on Monday, March […]
MIAMI CARDIAC & VASCULAR INSTITUTE BECOMES FIRST IN NORTH AMERICA TO USE NEW ROYAL PHILIPS TECHNOLOGY FOR INTERVENTIONAL PROCEDURES
CORAL GABLES, Fla. – Miami Cardiac & Vascular Institute, the largest and most comprehensive cardiovascular center in the South Florida region, is the first in the United States to use technology it developed, in partnership with Philips, that makes it easier for doctors to perform image guided procedures for heart […]
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial
CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC Davis Health (“UC Davis”) located in Sacramento, California to be the clinical trial site for the Company’s Phase II clinical trial […]
Hancock Jaffe Successfully Starts First-in-Human VenoValve Study
IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced the successful start of its VenoValve® first-in-human study in Bogota, Colombia. The first VenoValve was implanted in a patient and the procedure […]



